Synergy Rx GLP-1 Review vs PlexusDx (2026): Cost, Compounded Semaglutide, and the Genetics Most Telehealth Skips | PlexusDx

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Synergy Rx is one of the louder names in cash-pay compounded GLP-1 telehealth, advertising compounded semaglutide from $179/month, compounded tirzepatide from $349/month, and a LegitScript-certified operating model. If you're researching Synergy Rx, you're already comparing its sticker price against Wegovy, Zepbound, and a dozen other compounded-medication providers. This review walks through what Synergy Rx actually charges at maintenance dosing, the compounded vs FDA-approved branded distinction the page brushes past, the safety topics every prospective patient should weigh, and where PlexusDx Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 Protocol sit relative to Synergy Rx — because the practical decision isn't a one-line price comparison. It's medication source, dose-tier pricing across a full year, clinical-oversight model, and whether genetics inform your titration before week one.

What Synergy Rx actually is — the short version

Synergy Rx markets a telehealth GLP-1 weight-loss program operating in all 50 states, cash-pay only, with LegitScript certification and licensed U.S. physicians whose NPI numbers are publicly verifiable. The program dispenses both compounded GLP-1 medications (compounded semaglutide and compounded tirzepatide, prepared by state-licensed compounding pharmacies) and FDA-approved branded options (Wegovy, Ozempic, Mounjaro). Monthly pricing folds the clinician visit, the medication, injection supplies, and standard shipping into one bill. The platform does not bill insurance; HSA/FSA cards are typically accepted. Onboarding is async — an online health assessment, provider review within 24–48 hours, then pharmacy fulfillment shipped in 5–7 days. PlexusDx Weight Management Protocols use the same cash-pay, all-50-states framing, but layer in optional genetic testing through the Precision Peptide Genetic Test so the clinician sees your GLP1R, GIPR, FTO, and MC4R variants before titration.

Synergy Rx pricing at every dose tier

The $179/month headline is real but it's the entry-tier price for compounded semaglutide at the lowest starting dose. Synergy Rx's published structure scales to $249–$299/month at maintenance doses for compounded semaglutide. Compounded tirzepatide starts at $349/month and runs $349–$449/month dose-dependent. Brand-name FDA-approved options — Wegovy, Ozempic, Mounjaro — are listed at $499–$947/month at retail self-pay (Lilly Direct's Zepbound self-pay vials and Eli Lilly's discounted Wegovy retail program may be cheaper through the manufacturer directly). Annualized for a cash-pay patient who never qualifies for insurance: compounded semaglutide at Synergy Rx works out to roughly $2,148–$3,588/year depending on dose tier; compounded tirzepatide $4,188–$5,388/year; brand-name Wegovy or Zepbound $5,988–$11,364/year. PlexusDx Microdose GLP-1 Protocol runs $129/month flat ($1,548/year), Semaglutide Injection $149/mo ($2,148–$2,748/year), and Tirzepatide Injection $249/mo ($2,748–$3,708/year). On compounded tirzepatide specifically, PlexusDx's protocol pricing is substantially below Synergy Rx's $349–$449 range.

What patients actually report — the cash-pay reality

Synergy Rx's customer-facing reviews skew positive on three points: pricing transparency at the entry tier, the absence of bolt-on consultation or supply fees that several competitors charge, and provider responsiveness during the initial 24–48 hour review window. The friction points patients raise most often are dose escalation timing (compounded titration schedules vary by clinician), the cost step-up from $179 to maintenance pricing once dosing increases past the starter level, and the standard GLP-1 tolerability profile in the first 4–6 weeks regardless of provider. None of these are unique to Synergy Rx — they're inherent to the GLP-1 class. What's worth flagging: neither Synergy Rx nor most cash-pay competitors publish dose-specific outcome data the way the SUSTAIN, STEP, and SURMOUNT trials did for branded products, so weight-loss expectations cited on telehealth pages are typically extrapolated from those branded-trial results.

Cash-pay alternatives to Synergy Rx

The cash-pay GLP-1 market has three pricing archetypes worth understanding before you pick a provider. Compounded all-inclusive — Synergy Rx, MEDVi, Henry Meds, and PlexusDx all sit here, with monthly bundles covering the visit, medication, supplies, and shipping. PlexusDx's Microdose GLP-1 Protocol at $129/month flat is currently the lowest-priced compounded entry point in this archetype. Membership-plus-medication — Ro and similar platforms charge a $100–$150/month membership for clinical routing, then dispense FDA-approved branded products through partner pharmacies at retail or insurance pricing. Direct manufacturer cash-pay — Lilly Direct's Zepbound self-pay vials at ~$499/month and Eli Lilly and Novo Nordisk's evolving direct-to-consumer programs let cash-pay patients access FDA-approved branded products without a telehealth membership. PlexusDx adds a fourth category by pairing protocol pricing with the Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) so dosing is anchored to a measurable genetic baseline rather than a population-average titration schedule.

Compounded vs branded — what Synergy Rx and PlexusDx actually dispense

This is the substantive medication question and it deserves more space than telehealth landing pages give it. Synergy Rx's $179–$449/month tiers dispense compounded semaglutide and compounded tirzepatide — preparations made by state-licensed compounding pharmacies under U.S. compounding regulations. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products; they're pharmacy-prepared versions of the same active ingredients in Wegovy, Ozempic, Mounjaro, and Zepbound. Synergy Rx's higher-priced tiers ($499–$947) dispense the FDA-approved branded products themselves through partner pharmacies. PlexusDx Weight Management Protocols use compounded semaglutide and tirzepatide from licensed U.S. compounding pharmacies across four delivery formats: weekly injection (Semaglutide Injection, Tirzepatide Injection), daily oral tablet (Semaglutide Oral, Tirzepatide Oral), microdose troche/capsule/lozenge/sublingual (Microdose GLP-1 Protocol), and dual-compound stacks (GLP-Squared). PlexusDx does not currently dispense FDA-approved branded GLP-1s. Both providers' compounded products carry the same FDA-stated concerns: dosing-error risk, quality variability across pharmacies, and the absence of finished-product FDA approval. The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies regardless of whether the product is branded or compounded.

Why genetics belong in this decision

GLP-1 response varies meaningfully across patients, and the variation isn't random. Variants in GLP1R (the GLP-1 receptor itself), GIPR (the GIP receptor relevant to tirzepatide's dual mechanism), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide. The Precision Peptide Genetic Test maps 48 genes and 57 variants across 14 health pathways — including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response — so the prescribing clinician knows whether a faster-than-typical titration, a slower one, or a tirzepatide-first approach is more likely to fit your biology before week one. Synergy Rx does not perform this step; titration starts from a population-average schedule and adjusts based on subjective tolerability over the first 8–12 weeks. PlexusDx anchors that same conversation to a measurable genetic baseline, available standalone for $298 or as a $99 add-on after your first month on any protocol.

Synergy Rx vs PlexusDx — a four-question decision frame

Question 1: Are you paying cash and is price the dominant factor? Compare Synergy Rx's compounded semaglutide at $179–$299/month to PlexusDx Microdose GLP-1 Protocol at $129/month flat or Semaglutide Injection at $149/mo. On compounded tirzepatide, PlexusDx's $249/mo is meaningfully below Synergy Rx's $349–$449 range. Question 2: Do you specifically want an FDA-approved branded product (Wegovy, Ozempic, Mounjaro, Zepbound)? Synergy Rx offers branded options at the higher tiers; PlexusDx's protocols are compounded only. Question 3: Do you want a genetic baseline informing titration before the first dose? PlexusDx is the only option in this comparison that includes the Precision Peptide Genetic Test as part of the protocol pathway. Question 4: Do you want delivery options beyond weekly injection — oral tablets, microdose troches, sublingual? PlexusDx offers four delivery formats including Semaglutide Oral, Tirzepatide Oral, and GLP-Squared dual-compound; Synergy Rx's compounded path is primarily injection with limited oral dissolving-tablet options.

Frequently asked questions

Is Synergy Rx legit?

Yes — Synergy Rx is LegitScript certified, uses licensed U.S. physicians with verifiable NPI numbers, and partners with state-licensed compounding pharmacies. The legitimacy question is separate from the FDA-approval question: Synergy Rx's compounded medications are legally prepared but are not FDA-approved finished drug products. PlexusDx Weight Management Protocols use the same all-50-states, licensed-pharmacy operating model with optional genetic testing layered in.

How much does Synergy Rx actually cost at maintenance dosing?

Compounded semaglutide runs $179/month at the entry dose and $249–$299/month at maintenance. Compounded tirzepatide is $349–$449/month dose-dependent. Brand-name options are $499–$947/month. PlexusDx Semaglutide Injection is $149/mo and Tirzepatide Injection is $249/mo across all dose levels.

Is Synergy Rx FDA approved?

Synergy Rx is a telehealth platform, not a medication, so the question doesn't apply directly. The medications it dispenses split into two categories: brand-name Wegovy, Ozempic, Mounjaro, and Zepbound are FDA-approved finished drug products; compounded semaglutide and compounded tirzepatide are not FDA-approved. PlexusDx protocols dispense compounded products only.

Does Synergy Rx accept insurance?

No — Synergy Rx is cash-pay only. HSA/FSA payment is typically accepted. PlexusDx is also cash-pay with no membership fee, all 50 states (5 require a scheduled live consultation rather than async intake).

Is compounded semaglutide safe?

Compounded semaglutide from properly licensed pharmacies follows the same active-ingredient pharmacology as Wegovy and Ozempic. The FDA has flagged dosing-error risk and quality variability across compounded preparations. The boxed warning for thyroid C-cell tumors applies to compounded semaglutide based on rodent studies, the same as for branded products. Discuss any compounded GLP-1 with a licensed clinician before starting.

How much weight will I lose on a compounded GLP-1?

Compounded semaglutide and tirzepatide are not directly trial-tested for finished-product weight-loss outcomes. The branded SUSTAIN, STEP, and SURMOUNT trials reported average weight loss of roughly 15–21% over 12–18 months on the same active ingredients. Individual response varies meaningfully, and PlexusDx's Precision Peptide Genetic Test maps the genetic variants associated with that variability.

What happens if I stop the medication?

Studies of branded semaglutide and tirzepatide show roughly two-thirds of lost weight returns within one year of stopping. Plan for either long-term medication maintenance, a deliberate taper protocol with clinician oversight, or sustained lifestyle and dietary changes anchored to a metabolic baseline.

Related reading on PlexusDx

Related reading on PlexusDx: GLP-1 Cost, Semaglutide Cost, Tirzepatide Costs, Cheapest GLP-1.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for Synergy Rx is based on its published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.